#fda-regulation

#fda-regulation

But I saw many class actions and mass torts that seemed designed only to transfer money from pharmaceutical and medical device companies to plaintiffs' lawyers. Whether a drug or device actually harmed anyone was beside the point; anyone who was actually hurt could file their own individual lawsuit. The class actions and mass torts picked up the stragglers, whose situations didn't merit filing a case - people who overpaid for an allegedly dangerous drug

"Online pharmacies are advertising drugs with only upsides mentioned, contributing to America's culture of overreliance on pharmaceuticals for health," Makary wrote in a JAMA Network Open article focused on how the agency is overdue for a "crackdown on misleading pharmaceutical advertisements."

You see, until 1997, drug companies were required to include massive amounts of information about a drug's potential side effects and risks in any ads for it. The amount of information required could fit in, say, a full-page magazine ad - but it was far too much to squeeze into a 30- or 60-second TV spot. That meant pharmaceutical ads were, while not banned, almost unheard of on television.

After vapes staved off the extinction of tobacco, a new generation of nicotine products is promising a safer, albeit no less addictive, form of consumption through tobacco-free pouches made popular by the likes of Zyn and Velo. Now, a celebrity-backed upstart called Sesh is trying to challenge those incumbents. Buoyed by $40 million in venture funding from Palantir cofounder Joe Lonsdale's 8VC, along with music stars Diplo and Post Malone,